Inhibiting Tim-1 could reduce HCC proliferation, enhance the apoptotic effects of chemotherapy drugs, and hinder the ECM process, thereby slowing tumor progression and metastasis. This evidence concerns the gene HAVCR1 and hepatocellular carcinoma.